HIV prevention news: Europe

From 2012 to 2016, NAM published a monthly bulletin that covered HIV prevention news and research in Europe, and of relevance to Europe. It aimed to strengthen knowledge of new prevention options and share the latest HIV prevention news and research.

In that period, HIV prevention evolved rapidly, with landmark research developments in new prevention technologies and approaches, including HIV treatment as prevention (TasP), pre-exposure prophylaxis (PrEP), expanded testing programmes and advocacy for proven approaches that remain unprovided, such as syringe and needle exchange and condoms in prisons.

An archive of the bulletin is available in English, Spanish, Portuguese, French and Russian.

Archive

Issue #32 - November 2015

  • Conference news
  • At least 25,000 people in the US may now be using PrEP
  • Most migrants living with HIV in Europe acquired HIV in their new country
  • Peer workers improve drug users’ engagement with HIV care in Ukraine
  • London clinic survey shows impact of chemsex
  • Modest bone loss seen in young men taking Truvada for PrEP
  • Hepatitis C stays constant among HIV-positive gay men in Europe; varies across regions
  • Other recent news headlines
  • Editors' picks from other sources
  • European HIV Test Finder
  • HIV prevention bulletin
  • Acknowledgements

Issue #31 - September 2015

  • No HIV infections seen in San Francisco PrEP users referred via primary care
  • Spanish pharmacy HIV testing programme detects many new infections
  • HIV diagnosis rate high in Dutch STI clinics, but missed opportunities for diagnosis in primary care
  • Sexual transmission of HCV is increasing among gay and bisexual men with HIV
  • Studies find that viral undetectability is becoming part of people’s sex lives
  • A third of people with HIV intentionally miss HIV treatment doses when planning to drink or use drugs
  • Other recent news headlines
  • Editors' picks from other sources
  • HIV prevention bulletin
  • Acknowledgements

Issue #30 - August 2015

  • IAS Conference special
  • START trial finally clears way for HIV treatment for all
  • Non-daily PrEP will work for some
  • Studies show that those most at risk of HIV have the highest adherence to PrEP
  • Ukraine peer-educator project in people who use drugs almost halves HIV incidence
  • World Health Organization urges more HIV testing for those who need it most
  • A third to a half of African people with HIV living in France acquired it there
  • Eastern Europe has lower viral suppression rates than Africa
  • Other recent news headlines
  • HIV prevention bulletin
  • Acknowledgements

Issue #29 - July 2015

  • Most gay men in central Europe don’t know they have HIV
  • More than one in three Europeans with HIV is a migrant
  • HIV stigma associated with condomless casual sex in Europe…
  • …and depression associated with risky sex in Britain
  • Hepatitis C seen in HIV-negative gay men in London
  • Giving more gay men hepatitis C treatment could cut infections by two-thirds
  • Other recent news headlines
  • Editors' picks from other sources
  • HIV prevention bulletin
  • Acknowledgements

Issue #28 - May 2015

  • European hospital-testing project picks up many new HIV infections
  • First home test approved for sale in UK
  • Prioritising people at high risk will be crucial to the success of PrEP
  • Community involvement essential for success of HIV projects, reviews find
  • White drug injectors in New York have less HIV than the general population
  • Truvada PrEP causes only mild bone mineral loss
  • Other recent news headlines
  • Editors' picks from other sources
  • Work in HIV? We need your help!
  • HIV prevention bulletin
  • Acknowledgements

Issue #27 - April 2015

  • Most HIV-positive gay men in European survey are on HIV treatment: fewer in the east
  • More people in the UK are starting HIV treatment early to reduce transmission
  • PrEP use now could save money in the future
  • Opioid substitution treatment increases adherence to HIV therapy
  • Most US HIV infections transmitted by people who know they have HIV but aren’t in care
  • Good mental health associated with excellent adherence in people taking HIV treatment for prevention
  • Other recent news headlines
  • Editors' picks from other sources
  • Work in HIV? We need your help!
  • HIV prevention bulletin
  • Acknowledgements

Issue #26 - March 2015

  • Conference special – news from CROI 2015
  • Two European PrEP studies report very high effectiveness
  • Tenofovir microbicide gel fails in South African study
  • PrEP use is becoming normalised in San Francisco
  • Mixing PrEP and treatment almost eliminates infections in African couples
  • No transmissions from HIV-positive partner seen in Australian gay-couple study
  • Weekend-off HIV treatment is popular and effective for young people
  • Other recent news headlines
  • Editors' picks from other sources
  • Work in HIV? We need your help!
  • HIV prevention bulletin
  • Acknowledgements

Issue #25 - February 2015

  • Gay men’s project in Russia and Hungary boosts condom use: may have brought down HIV rate
  • US researchers publish estimate of condom effectiveness in anal sex
  • HIV is becoming more virulent over time in Europe
  • Most HIV in gay men passed between younger, undiagnosed partners who know each other
  • Gay men are better at predicting when they won’t have sex than when they will
  • The most effective HIV prevention method for teenage girls in Africa? Keep them in school.
  • Other recent news headlines
  • Editors' picks from other sources
  • Work in HIV? We need your help!
  • HIV prevention bulletin
  • Acknowledgements
2024202320222021202020192018201720162015201420132012

This project has been supported via a grant from Gilead Sciences Europe Ltd, Merck & Co., Inc. and ViiV Healthcare.

Gilead Sciences Europe Ltd, Merck & Co., Inc. and ViiV Healthcare have provided funding for this project and have had no editorial control over the content of the materials.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.